Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression

XX Wu, S Guller, JH Rand - American journal of obstetrics and gynecology, 2011 - Elsevier
OBJECTIVE: Antibody-mediated disruption of the annexin A5 anticoagulant shield has been
posited to be a thrombogenic mechanism in the antiphospholipid syndrome. We recently …
被引用次数：93 相关文章

Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression

XX Wu, S Guller, JH Rand - American Journal of Obstetrics and …, 2011 - infona.pl
Antibody-mediated disruption of the annexin A5 anticoagulant shield has been posited to be
a thrombogenic mechanism in the antiphospholipid syndrome. We recently showed that the …

Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression

XX Wu, S Guller, JH Rand - American Journal of Obstetrics & Gynecology, 2011 - ajog.org
Objective Antibody-mediated disruption of the annexin A5 anticoagulant shield has been
posited to be a thrombogenic mechanism in the antiphospholipid syndrome. We recently …

Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression

XX Wu, S Guller, JH Rand - American journal of obstetrics …, 2011 - pubmed.ncbi.nlm.nih.gov
Objective Antibody-mediated disruption of the annexin A5 anticoagulant shield has been
posited to be a thrombogenic mechanism in the antiphospholipid syndrome. We recently …

Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression.

XX Wu, S Guller, JH Rand - American Journal of Obstetrics and …, 2011 - europepmc.org
Objective Antibody-mediated disruption of the annexin A5 anticoagulant shield has been
posited to be a thrombogenic mechanism in the antiphospholipid syndrome. We recently …
[HTML] nih.gov

[HTML][HTML] HYDROXYCHLOROQUINE REDUCES BINDING OF ANTIPHOSPHOLIPID ANTIBODIES TO SYNCYTIOTROPHOBLASTS AND RESTORES ANNEXIN A5 …

XX Wu, S Guller, JH Rand - American journal of obstetrics and …, 2011 - ncbi.nlm.nih.gov
Objectives Antibody-mediated disruption of the annexin A5 (AnxA5) anticoagulant shield
has been posited to be a thrombogenic mechanism in the antiphospholipid syndrome. We …

Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression.

XX Wu, S Guller, JH Rand - American Journal of Obstetrics and …, 2011 - europepmc.org
Objective Antibody-mediated disruption of the annexin A5 anticoagulant shield has been
posited to be a thrombogenic mechanism in the antiphospholipid syndrome. We recently …